Meinian Onehealth Healthcare Holdings Co., Ltd. (002044.SZ)
CNY 5.34
(2.69%)
CNY 5.34
(2.69%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 10.88 Billion CNY | 27.59% |
| 2022 | 8.53 Billion CNY | -6.8% |
| 2021 | 9.15 Billion CNY | 17.16% |
| 2020 | 7.81 Billion CNY | -8.33% |
| 2019 | 8.52 Billion CNY | 0.79% |
| 2018 | 8.45 Billion CNY | 35.7% |
| 2017 | 6.23 Billion CNY | 102.25% |
| 2016 | 3.08 Billion CNY | 46.65% |
| 2015 | 2.1 Billion CNY | 193.49% |
| 2014 | 716.03 Million CNY | -6.92% |
| 2013 | 769.23 Million CNY | 11.29% |
| 2012 | 691.21 Million CNY | -10.97% |
| 2011 | 776.35 Million CNY | 40.06% |
| 2010 | 554.31 Million CNY | 8.72% |
| 2009 | 509.83 Million CNY | 23.45% |
| 2008 | 412.98 Million CNY | -27.07% |
| 2007 | 566.29 Million CNY | -4.3% |
| 2006 | 591.71 Million CNY | 11.93% |
| 2005 | 528.66 Million CNY | -6.21% |
| 2004 | 563.65 Million CNY | 26.12% |
| 2003 | 446.92 Million CNY | 33.33% |
| 2002 | 335.19 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 2.93 Billion CNY | 22.13% |
| 2024 Q2 | 2.4 Billion CNY | 33.46% |
| 2024 Q1 | 1.8 Billion CNY | -50.98% |
| 2023 Q1 | 2.09 Billion CNY | -24.68% |
| 2023 Q4 | 3.67 Billion CNY | 30.61% |
| 2023 FY | 10.88 Billion CNY | 27.59% |
| 2023 Q3 | 2.81 Billion CNY | 21.74% |
| 2023 Q2 | 2.3 Billion CNY | 10.22% |
| 2022 FY | 8.53 Billion CNY | -6.8% |
| 2022 Q1 | 1.35 Billion CNY | -59.22% |
| 2022 Q2 | 1.57 Billion CNY | 16.15% |
| 2022 Q3 | 2.82 Billion CNY | 80.19% |
| 2022 Q4 | 2.78 Billion CNY | -1.65% |
| 2021 Q1 | 1.33 Billion CNY | -60.78% |
| 2021 FY | 9.15 Billion CNY | 17.16% |
| 2021 Q2 | 2.04 Billion CNY | 53.51% |
| 2021 Q3 | 2.46 Billion CNY | 20.51% |
| 2021 Q4 | 3.31 Billion CNY | 34.49% |
| 2020 Q2 | 1.27 Billion CNY | 139.06% |
| 2020 Q4 | 3.39 Billion CNY | 30.39% |
| 2020 Q3 | 2.6 Billion CNY | 103.58% |
| 2020 FY | 7.81 Billion CNY | -8.33% |
| 2020 Q1 | 535.14 Million CNY | -76.19% |
| 2019 Q2 | 2.36 Billion CNY | 84.72% |
| 2019 FY | 8.52 Billion CNY | 0.79% |
| 2019 Q1 | 1.27 Billion CNY | -51.56% |
| 2019 Q3 | 2.63 Billion CNY | 11.61% |
| 2019 Q4 | 2.24 Billion CNY | -14.75% |
| 2018 Q2 | 2.25 Billion CNY | 84.5% |
| 2018 FY | 8.45 Billion CNY | 35.7% |
| 2018 Q1 | 1.22 Billion CNY | -62.24% |
| 2018 Q4 | 2.63 Billion CNY | 15.72% |
| 2018 Q3 | 2.28 Billion CNY | 0.94% |
| 2017 FY | 6.23 Billion CNY | 102.25% |
| 2017 Q1 | 554.99 Million CNY | -53.72% |
| 2017 Q4 | 3.24 Billion CNY | 137.15% |
| 2017 Q3 | 1.36 Billion CNY | 28.27% |
| 2017 Q2 | 1.06 Billion CNY | 92.14% |
| 2016 FY | 3.08 Billion CNY | 46.65% |
| 2016 Q1 | 309 Million CNY | -62.03% |
| 2016 Q2 | 733.52 Million CNY | 137.38% |
| 2016 Q4 | 1.19 Billion CNY | 42.75% |
| 2016 Q3 | 840.07 Million CNY | 14.53% |
| 2015 Q3 | 581.01 Million CNY | 315.29% |
| 2015 Q1 | 103.09 Million CNY | -49.03% |
| 2015 FY | 2.1 Billion CNY | 193.49% |
| 2015 Q2 | 139.9 Million CNY | 35.71% |
| 2015 Q4 | 813.76 Million CNY | 40.06% |
| 2014 Q3 | 287.09 Million CNY | 101.76% |
| 2014 FY | 716.03 Million CNY | -6.92% |
| 2014 Q4 | 202.25 Million CNY | -29.55% |
| 2014 Q2 | 142.29 Million CNY | 68.63% |
| 2014 Q1 | 84.38 Million CNY | -68.04% |
| 2013 Q3 | 261.11 Million CNY | 117.98% |
| 2013 Q4 | 264.07 Million CNY | 1.13% |
| 2013 FY | 769.23 Million CNY | 11.29% |
| 2013 Q1 | 124.25 Million CNY | -41.43% |
| 2013 Q2 | 119.78 Million CNY | -3.59% |
| 2012 Q2 | 117.95 Million CNY | -8.64% |
| 2012 FY | 691.21 Million CNY | -10.97% |
| 2012 Q4 | 212.14 Million CNY | -8.56% |
| 2012 Q3 | 232.01 Million CNY | 96.7% |
| 2012 Q1 | 129.1 Million CNY | -34.48% |
| 2011 Q2 | 175.58 Million CNY | 35.76% |
| 2011 FY | 776.35 Million CNY | 40.06% |
| 2011 Q4 | 197.03 Million CNY | -28.2% |
| 2011 Q3 | 274.41 Million CNY | 56.29% |
| 2011 Q1 | 129.33 Million CNY | -34.72% |
| 2010 FY | 554.31 Million CNY | 8.72% |
| 2010 Q2 | 80.67 Million CNY | -22.65% |
| 2010 Q3 | 171.23 Million CNY | 112.25% |
| 2010 Q1 | 104.29 Million CNY | -38.81% |
| 2010 Q4 | 198.1 Million CNY | 15.69% |
| 2009 Q4 | 170.44 Million CNY | 6.75% |
| 2009 Q2 | 80.8 Million CNY | -18.31% |
| 2009 Q3 | 159.67 Million CNY | 97.61% |
| 2009 FY | 509.83 Million CNY | 23.45% |
| 2009 Q1 | 98.91 Million CNY | -29.95% |
| 2008 Q4 | 141.2 Million CNY | 30.85% |
| 2008 Q2 | 80.11 Million CNY | -4.33% |
| 2008 FY | 412.98 Million CNY | -27.07% |
| 2008 Q3 | 107.91 Million CNY | 34.7% |
| 2008 Q1 | 83.74 Million CNY | -42.85% |
| 2007 FY | 566.29 Million CNY | -4.3% |
| 2007 Q2 | 116.81 Million CNY | -7.24% |
| 2007 Q3 | 177 Million CNY | 51.52% |
| 2007 Q4 | 146.53 Million CNY | -17.22% |
| 2007 Q1 | 125.94 Million CNY | -18.36% |
| 2006 Q3 | 151.18 Million CNY | 0.66% |
| 2006 FY | 591.71 Million CNY | 11.93% |
| 2006 Q4 | 154.25 Million CNY | 2.03% |
| 2006 Q1 | 136.08 Million CNY | 5.41% |
| 2006 Q2 | 150.18 Million CNY | 10.36% |
| 2005 Q4 | 129.1 Million CNY | -29.8% |
| 2005 Q2 | 92.86 Million CNY | -24.38% |
| 2005 Q1 | 122.79 Million CNY | -25.47% |
| 2005 Q3 | 183.9 Million CNY | 98.05% |
| 2005 FY | 528.66 Million CNY | -6.21% |
| 2004 Q3 | 182.03 Million CNY | 0.0% |
| 2004 Q4 | 164.76 Million CNY | -9.49% |
| 2004 FY | 563.65 Million CNY | 26.12% |
| 2003 FY | 446.92 Million CNY | 33.33% |
| 2002 FY | 335.19 Million CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| C.Q. Pharmaceutical Holding Co., Ltd. | 80.11 Billion CNY | 86.411% |
| Aier Eye Hospital Group Co., Ltd. | 20.36 Billion CNY | 46.546% |